Screening for Regulatory Network of miRNA–Inflammation, Oxidative Stress and Prognosis-Related mRNA in Acute Myocardial Infarction: An in silico and Validation Study
Xunli Yin,Xuebing Wang,Shiai Wang,Youwei Xia,Huihui Chen,Ling Yin,Keqing Hu
DOI: https://doi.org/10.2147/IJGM.S354359
IF: 2.145
2022-02-18
International Journal of General Medicine
Abstract:Xunli Yin, 1 Xuebing Wang, 1 Shiai Wang, 1 Youwei Xia, 2 Huihui Chen, 1 Ling Yin, 3 Keqing Hu 4 1 Department of Cardiovascular Medicine, The Seventh People's Hospital of Jinan, Jinan, 250100, People's Republic of China; 2 Department of Critical Care Medicine, The Seventh People's Hospital of Jinan, Jinan, 250100, People's Republic of China; 3 Department of Conduit Room, The Seventh People's Hospital of Jinan, Jinan, 250100, People's Republic of China; 4 Cardiovascular Department, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, People's Republic of China Correspondence: Keqing Hu, Central Hospital Affiliated to Shandong First Medical University, Cardiovascular Department,105#, Jiefang Road, Jinan 250013, Shandong, China, Tel +86 0531-85695114, Fax +86 0531-86942457 Email Background: Acute myocardial infarction (AMI), which commonly leads to heart failure, is among the leading causes of mortality worldwide. The aim of this study was to find potential regulatory network for miRNA-inflammation, oxidative stress and prognosis-related mRNA to uncover molecular mechanisms of AMI. Methods: The expression profiles of miRNA and mRNA in the blood samples from AMI patients were downloaded from the Gene Expression Omnibus (GEO) dataset for differential expression analysis. Weighted gene co-expression network analysis (WGCNA) was used to further identify important mRNAs. The negatively regulatory network construction of miRNA–inflammation, oxidative stress and prognosis-related mRNAs was performed, followed by protein–protein interaction (PPI) and functional analysis of mRNAs. Results: A total of three pairs of negatively regulatory network of miRNA–inflammation and prognosis-related mRNAs (hsa-miR-636/hsa-miR-491-3p/hsa-miR-188-5p/hsa-miR-188-3p-AQP9, hsa-miR-518a-3p-C5AR1 and hsa-miR-509-3-5p/hsa-miR-127-5p-PLAUR), two pairs of negatively regulatory network of miRNA–oxidative stress and prognosis-related mRNAs (hsa-miR-604-TLR4 and hsa-miR-139-5p-CXCL1) and three pairs of negatively regulatory network of miRNA-inflammation, oxidative stress and prognosis-related mRNA (hsa-miR-634/hsa-miR-591-TLR2, hsa-miR-938-NFKBIA and hsa-miR-520h/hsa-miR-450b-3p-ADM) were identified. In the KEGG analysis, some signaling pathways were identified, such as complement and coagulation cascades, pathogenic Escherichia coli infection, chemokine signaling pathway and cytokine–cytokine receptor interaction and Toll-like receptor signaling pathway. Conclusion: Identified negatively regulatory network of miRNA-inflammation/oxidative stress and prognosis-related mRNA may be involved in the process of AMI. Those inflammation/oxidative stress and prognosis-related mRNAs may be diagnostic and prognostic biomarkers for AMI. Keywords: acute myocardial infarction, miRNAs, mRNAs, prognosis, inflammation, oxidative stress Acute myocardial infarction (AMI), one of the major cardiovascular diseases that lead to a high morbidity and mortality, is commonly defined as a cardiomyocyte death due to the prolonged ischaemia. 1 In addition, other risk factors including age, size and location of infarct, and haemodynamic status are associated with AMI. 2 The improved survival rates have been observed in AMI patients. 3,4 However, recurrent patients with AMI, a higher risk subgroup of those with AMI, have worse outcomes. 5–7 Therefore, it is needed to identify potential prognostic indicators to prevent AMI patients from relapsing. Previous reports showed that the age, creatinine, ejection fraction score and SYNTAX Score II had a prognostic value for patients with ST-elevation myocardial infarction-related cardiogenic shock. 8,9 MI is a primarily local event, which results in the activation of the acute systemic inflammatory response. Reactive oxygen species (ROS) play a crucial role in MI. 10 In heart cells, the ROS causes mitochondrial dysfunction and result in serious complications, such as remodeling of the left ventricle and infarct expansion after MI. 11 It is noted that oxidative stress also up-regulated synthesis of pro-inflammatory cytokine. 12 Therefore, novel therapeutic strategy against AMI intends to control both the inflammatory response and the oxidative stress. MiRNAs regulate mRNA expression at the post-transcriptional level. 13,14 MiRNAs have emerged as a kind of promising tool associated with some pathophysiological processes, including cardiovascular diseases. In addition, weighted gene co-expression network analysis (WGCNA) is used to elucidate changes in transcriptome expression patterns in complex diseases. 15–17</ -Abstract Truncated-
medicine, general & internal